SCHEMBL14280466

SCHEMBL14280466

CC(C)(C)NC(=O)N1CCC2(CC1)C(=O)N(c1ccc(CNC=O)cc1)C2c1ccc(-c2ccccc2)cc1

nearest known ligand 0.51

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
TRPV1 Q8NER1 8/20 0.51
CACNA1H O95180 12/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14280325 0.89 TRPV1 (0.53) TRPV1CACNA1H
SCHEMBL8209202 0.78 CACNA1H (0.54) TRPV1CACNA1H
SCHEMBL14265956 0.78 TRPV1 (0.41) TRPV1CACNA1H
SCHEMBL14280511 0.75 TRPV1 (0.52) TRPV1CACNA1H
SCHEMBL8201876 0.75 CACNA1H (0.51) TRPV1CACNA1H
SCHEMBL8217835 0.73 TRPV1 (0.55) TRPV1
SCHEMBL8217839 0.71 CACNA1H (0.49) TRPV1CACNA1H
SCHEMBL8212614 0.70 TP53 (0.55) TRPV1CACNA1H
SCHEMBL14265957 0.69 TRPV1 (0.59) TRPV1CACNA1H
SCHEMBL8210251 0.68 TRPV1 (0.62) TRPV1CACNA1H

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008033431-A1 SPIROCYCLIC AZETIDINONE DERIVATIVES FOR THE TREATMENT OF DISORDERS OF LIPID METABOLISM, PAIN, DIABETES AND OTHER DISORDERS SCHERING CORPORATION (US) 2008-03-20 WO disclosed